Breakthrough Device Designation granted to the AI Software for CTEPH

  • Home Blog Fda alert breakthrough device designation granted to the artificial intelligence software for cteph

Breakthrough Device Designation granted to the AI Software for CTEPH

Dec 05, 2018

FDA

FDA

Downloads

Article in PDF

Recent Articles
  1. FDA Approves RINVOQ for Crohn’s Disease; FDA Approves Krystal Biotech’s Gene Therapy Vyjuve...
  2. AbbVie Receives Approval; Kymriah Approved; Shire Gets USFDA Approval; NICE Rejects; Bristol-Myer...
  3. Notizia
  4. Artificial Intelligence (AI) in Respiratory Care: An Opportune Time for Adoption in Clinical Sett...
  5. Medical Odyssey: Solving the Dynamic Puzzle of Global Tourism Market
pharma-news-for-boston-scientific-roche-northstrive
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Boston Scientific Pushes Forward Despite $200M Tariff Challenge; Northstrive Biosciences Gets FDA Green Light to Advance EL-22 Obesity Trial; Roche Acts Swiftly to Offset U.S. Tariff Impact with Global Engagements; Verastem Oncology Secures IND Clearance for KRAS G12D Inhibitor Trial; BlackfinBio Gets FDA OK for Phase I/II Trial of BFB-101 in SPG47

ai-in-mental-health-diagnosis-and-treatment
Articles

Exploring the Impact of AI in Mental Health: How it is Going to Revolutionize Diagnosis and Treatment for a Better Tomorrow?

pharma-news-for-regeneron-gilead-neuronos
Notizia - Recent Pharma, Healthcare and Biotech Happenings

FDA Approves Sanofi/Regeneron’s DUPIXENT as First New CSU Therapy in Over a Decade; Gilead’s TRODELVY + KEYTRUDA Shows PFS Benefit in PD-L1+ TNBC; Tempest’s TPST-1495 Gets FDA Orphan Tag for FAP; uniQure’s AMT-130 Granted FDA Breakthrough for Huntington’s; NeuroNOS’ BA-102 Secures FDA Orphan Status for Phelan-McDermid Syndrome

AI Software
artificial intelligence
CTEPH
FDA
loader